Topline data for RAPIDe-3, a pivotal Phase 3 study of deucrictibant immediate-release capsule for the on-demand treatment of HAE attacks, expected in 4Q2025Enrollment in CHAPTER-3, a pivotal Phase 3 ...

DC Market Insights announces the publication of its latest study on the North America Edge Data Center Market, detailing robust growth fueled by 5G rollouts, distributed AI/ML, and real‑time digital ...

Positive Phase 1 data for CTX310® presented in a late-breaking presentation at the American Heart Association (AHA) Scientific Sessions and ...